TITLE

An acute need for awareness of insulin injection guidelines in operative and intensive care units

AUTHOR(S)
Bajwa, Sukhminder Jit Singh; Kalra, Sanjay; Baruah, Manash P.; Bajwa, Sukhwinder Kaur
PUB. DATE
January 2013
SOURCE
Anesthesia: Essays & Researches;Jan-Apr2013, Vol. 7 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The authors discuss an acute need for awareness of insulin injection guidelines in operative and intensive care units due to the increasing number of critically ill diabetic patients. They examine the significance of insulin injection techniques. They look at the complications of insulin injections. They also cite new guidelines for insulin injection practices.
ACCESSION #
89187677

 

Related Articles

  • Insulin Analogs--Is There a Compelling Case to Use Them? No! Davidson, Mayer B. // Diabetes Care;Jun2014, Vol. 37 Issue 6, p1771 

    The article presents the reasons discouraging the use of analog insulin in diabetics, based on pharmacokinetic and pharmacodynamic data. Topics discussed include the global including sales cost in 2011, outcomes in randomized control trials comparing analog and human insulin and results of...

  • 7. Approaches to Glycemic Treatment.  // Diabetes Care;2015 Supplement, Vol. 38, pS41 

    The article focuses on glycemic treatment approaches for type 1 diabetes patients according to the American Diabetes Association's Standards of Medical Care in Diabetes. Topics discussed include treatment with multiple-dose insulin (MDI) injections or continuous subcutaneous insulin infusion...

  • Unproven Therapies.  // Diabetes Care;Jan2002 Supplement, Vol. 25, pS133 

    Presents the position statement of the American Diabetes Association (ADA) regarding the use of unproven therapies for patients with diabetes in the United States. Characteristics of unproven therapies; Characteristics of therapeutic modalities according to the ADA; Standards of the ADA...

  • Insulin siting. R.M.D. // Cortlandt Forum;10/25/96, Vol. 9 Issue 10, p117 

    States that a diabetic patient's failure to rotate sites of insulin administration may result in pain and local tissue atrophy.

  • New standards back down from intensive glucose control in hospitals. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;3/1/2010, Vol. 67 Issue 5, p335 

    The article focuses on the standards of the American Diabetes Association for intensive glucose control of critically ill patients in hospitals. Study suggests that targeting a glucose of 110 milligram per deciliter (mg/dL) for intensive care unit (ICU) patients should be stopped. An...

  • Making Intensified Insulin Treatment Safer. Boden, Guenther; Hoeldtke, Robert D. // Annals of Internal Medicine;Aug83, Vol. 99 Issue 2, p268 

    Discusses the issue of safety of therapeutic approaches to normalize blood sugar levels in diabetic patients. Advances in the understanding of acute glucose counterregulation; Details of intensified insulin treatment; Risk factors to counterregulatory hormone release.

  • Insulin protocols for hospital management of diabetes. Farquhar, Andrew // Canadian Family Physician;Oct2007, Vol. 53 Issue 10, p1668 

    The article presents information on the medical protocols that are carried out to improve the management of diabetes in hospitals. The basal-bolus approach, which steers from the use of sliding scale regular insulin is discussed, along with the function of the treatment. It is mentioned that...

  • Introduction.  // Diabetes Care;2015 Supplement, Vol. 38, pS1 

    An introduction to the journal is presented in which the Standards of Medical Care in Diabetes, by the American Diabetes Association (ADA), is discussed.

  • Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes? Schwartz, Stanley; DeFronzo, Ralph A. // Diabetes Care;Feb2014, Vol. 37 Issue 2, pe42 

    A response to a commentary on a study that investigated the use of incretin-based therapy for hospitalized patients with hyperglycemia is presented. They assert that the results support their claim that glucagon-like peptide 1 (GLP-1) therapy represents a safe and effective intervention for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics